Cargando…
Exposure to chemotherapeutic agents and the risk of a second breast cancer: preliminary findings.
Chemotherapeutic treatment for cancer has been successful in prolonging survival but may also lead to the development of second cancers. Two case-control studies presented here suggest, however, that breast cancer patients who receive chemotherapy are at significantly lower risk of a contralateral b...
Autores principales: | Horn, P. L., Thompson, W. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590453/ https://www.ncbi.nlm.nih.gov/pubmed/3176526 |
Ejemplares similares
-
Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949) -
APC selectively mediates response to chemotherapeutic agents in breast cancer
por: VanKlompenberg, Monica K., et al.
Publicado: (2015) -
Erratum to: APC selectively mediates response to chemotherapeutic agents in breast cancer
por: VanKlompenberg, Monica K., et al.
Publicado: (2016) -
In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
por: Siemann, D. W.
Publicado: (1981) -
Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells
por: Li, Hai-zhi, et al.
Publicado: (2008)